PROOF Centre Uses Genome BC Funds for COPD Dx | GenomeWeb

This article has been updated with the names of the partners providing funding.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canada's Prevention of Organ Failure (PROOF) Centre of Excellence in Vancouver will use C$1.5 million (US$1.5 million) in new funding to develop a biomarker-based test for determining a person's risk for having a lung attack.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.